Leef Brands (LEEEF) Income from Continuing Operations (2025 - 2026)
Leef Brands (LEEEF) reported Income from Continuing Operations of 426253.0 for Q1 2026, down 260.38% on a YoY basis from 265776.0 in Q1 2025, and down 260.38% sequentially from 265776.0 in Q1 2025.
Leef Brands (LEEEF) Income from Continuing Operations (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of Income from Continuing Operations data on file, last reported at 426253.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Leef Brands | 51.81 Mn | 46.05 Mn | 4.62 Mn | -426,253.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -426,253.00 |
| Mar 31, 2025 | 265,776.00 |